« Back to Record
Citation APA

Risi, E., Biagioni, C., Benelli, M., Migliaccio, I., McCartney, A., Bonechi, M., Guarducci, C., Hilbers, F. F., Di Cosimo, S., Huober, J., Romagnoli, D., Boccalini, G., Vitale, S., Sotiriou, C., Biganzoli, L., Di Leo, A., & Malorni, L. (2019). An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06). Therapeutic advances in medical oncology, 11. doi:10.1177/1758835919891608


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/298688

Risi, E., Biagioni, C., Benelli, M., Migliaccio, I., McCartney, A., Bonechi, M., Guarducci, C., Hilbers, F. F., Di Cosimo, S., Huober, J., Romagnoli, D., Boccalini, G., Vitale, S., Sotiriou, C., Biganzoli, L., Di Leo, A., & Malorni, L. (2019). An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06). Therapeutic advances in medical oncology, 11. doi:10.1177/1758835919891608